Cash in Exchange for Shares

Venture Capital on Ulitzer

Subscribe to Venture Capital on Ulitzer: eMailAlertsEmail Alerts newslettersWeekly Newsletters
Get Venture Capital on Ulitzer: homepageHomepage mobileMobile rssRSS facebookFacebook twitterTwitter linkedinLinkedIn


Top Stories

NEWPORT BEACH, Calif., May 5 /PRNewswire-FirstCall/ -- Nationwide Health Properties, Inc. (NYSE: NHP) announced today that our Board of Directors declared a $0.44 per share dividend on our common stock that will be paid on June 5, 2009 to shareholders of record on May 15, 2009. In addition, our Board of Directors declared a $1.9375 per share dividend on our Series B cumulative convertible preferred stock that will be paid on June 30, 2009 to shareholders of record on June 15, 2009. Nationwide Health Properties, Inc. is a real estate investment trust (REIT) that invests primarily in healthcare real estate in the United States. As of March 31, 2009, the Company's portfolio of properties, including mortgage loans and properties owned by unconsolidated joint ventures, totaled 579 properties among the following segments: 279 senior housing facilities, 200 skilled nursi... (more)

ForSight VISION3, Inc. Announces Appointment of Bernard Haffey as President and CEO

MENLO PARK, Calif. and BOSTON, April 9 /PRNewswire/ -- ForSight VISION3, Inc. announced today the appointment of Bernard Haffey as President and CEO to lead the company in its mission to become the first choice in corneal refractive surgery. ForSight VISION3, Inc. is the third spin out company from ophthalmic incubator ForSight Labs, LLC. "Bernie Haffey has been a key driver of multiple breakthrough technologies in ophthalmology over the past 15 years," said Bill Link, Managing Director at Versant Ventures and Chairman of the Board of ForSight VISION3, Inc. "His experience makes him uniquely qualified to guide ForSight VISION3 to be a market leader. Ophthalmology continues to be an exciting investment field and we are extremely fortunate to welcome Bernie's leadership and strategic expertise to VISION3." Mr. Haffey is a veteran executive in ophthalmology and has... (more)

BrightRoll Secures $30 Million in Funding

LONDON, November 17, 2011 /PRNewswire/ -- Investment Amid Continued Expansion of Network, Exchange and Mobile Video Solutions BrightRoll, the leading provider of digital video advertising services, announces it has secured US $30 million (£18.9 million) in financing. New investor Trident Capital  led the equity financing and Evangelos Simoudis, Senior Managing Director of Trident will be joining the BrightRoll board.  Existing investors True Ventures, Scale Venture Partners and Adams Street Partners all participated, as did Comerica Bank.  Earlier this year, BrightRoll - which has headquarters in San Fancisco - expanded internationally opening offices in the UK, Canada and Germany, bringing the company's industry-leading technologies and extensive suite of digital video solutions to global advertisers. This funding comes amid significant momentum as BrightRoll cont... (more)

SCRA Releases 2011 Annual Reports

SCRA, an emerging global leader in applied research and commercialization, today released two 2011 annual reports. The two annual reports outline the successes of both SCRA and SCRA Technology Ventures’ flagship SC Launch program. The SCRA annual report summarizes the many accomplishments achieved throughout 2011 for SCRA’s Technology Ventures, Applied R&D and R&D Facilities sectors, plus the cross-sector operations that support the company, its clients and partners. In its 28 year history, SCRA has grown significantly, with record revenues of $195 million achieved in 2011, up 13 percent from the prior Fiscal Year. Much of the growth has been attained during the past six years, with revenues increasing by over 160 percent throughout the timeframe. A recent USC Moore School economic output study measured SCRA’s contributions to South Carolina’s economy at $1.45 bi... (more)

Don Urbanowicz to Host "Top 10 Value-Drivers Strategics Look for in Pre-Revenue Startups" Session at Elsevier Business Intelligence's 'IN3 Medical Device 360° Boston' Conference

BOSTON, MA -- (Marketwire) -- 05/22/12 -- Elsevier Business Intelligence, the medtech industry's leading provider of strategic partnership and investment conferences, announced today that 30-year device industry veteran Don Urbanowicz, Principal, Urbanowicz Consulting, LLC, will host an early-stage start-up investment strategy session at the 'Investment in Innovation (IN3) Medical Device 360° Boston' investor conference, June 27-29, 2012, at the Hyatt Regency Boston. Urbanowicz, former senior-level executive with Stryker Orthopaedics, Sofamor Danek, Aircast and Smith & Nephew, will host a one-hour session on Thursday evening, June 28th, titled "Top 10 Value-Drivers Strategics Look for in Pre-Revenue Startups," which will examine in detail what medical device acquirers or licensors are specifically looking for in pre-revenue companies, and describe how startups can ... (more)

GrowFL Clients Recognized As 2012 Innovators In Business By Governor Rick Scott

ORLANDO, Fla., Dec. 14, 2012 /PRNewswire-USNewswire/ -- Winners of the 2012 Governor's Innovators in Business awards were announced this week. These awards recognize outstanding contributions toward improving Florida's economy and community investment.  Award recipients are primarily judged on their economic development impact and high wage job growth. GrowFL, the Florida Economic Gardening Institute at the University of Central Florida, are pleased to congratulate their clients and those who are recent Florida Companies to Watch winners. Flagship Solutions Group in Palm Beach County (CEO Mark A. Wyllie) received the Governor's Innovation & Entrepreneurship Award, in the Mega Market category, for Florida start-up companies that have set a standard for entrepreneurship and creativity. The Governor's Innovators Under 40 Award was presented to several GrowFL clients a... (more)

The Top 10 Largest Private Equity Deals of 2012: PRIVCO

NEW YORK, NY -- (Marketwire) -- 01/25/13 -- PrivCo, the leading private company financial data provider (www.PrivCo.com), has just released its annual rankings of the Top 10 Largest Private-Equity Deals of the Year. The Top 10 Largest Private-Equity Deals for 2012: 1. $7.2 Billion - EP ENERGY CORP (Headquarters: Houston, TX) Acquired By P.E. Buyers: Apollo, Riverstone, Access Industries, Korea National Oil Corporation 2. $6.6 Billion - CEQUEL COMMUNICATIONS (St. Louis, MO) Acquired By BC Partners, Canada Pension Plan Investment Board 3. $4.9 Billion - DUPONT PERFORMANCE COATINGS (Wilmington, DE) Acquired By Carlyle 4. $3.7 Billion - FOCUS MEDIA (Shanghai, China) Acquired By Carlyle, Fountainvest, China Everbright, CITIC Capital, Jason Nanchun Jiang 5. $3.5 Billion - HAMILTON SUNDSTRAND INDUSTRIAL (Windsor Locks, CT) Acquired By Carlyle, BC Partners 6. $3.3 Billion - GETTY... (more)

Chevrolet Unveils Branded Wayin Hub at SXSWi for Unparalled Social Engagement

SXSW Interactive 2013 – Booth #623 – Wayin, the online social engagement company, today announced Chevrolet is using the company’s newest offering, Wayin Hub, to amplify their social engagement at SXSW. Wayin Hub empowers companies like Chevrolet with a flexible, fully customizable way to organize, visualize and activate engagement around their brands. Chevrolet is utilizing Wayin Hub to help activate their SXSW sponsorship by visualizing engaging content from Twitter and Instagram. In addition to displaying user-generated content, their Wayin powered SXSW Hub will also include information about Chevrolet-sponsored events and other SXSW related content. Chevrolet’s SXSW Hub can be found at www.chevrolet.com/SXSW. “In this instance, Wayin Hub gives SXSW attendees the ability to interact with the Chevy brand in a fun and meaningful way,” said Wayin CEO, Tom Jessiman. ... (more)

VivaKi and Mass Relevance Announce Partnership, Empowering Agencies to Drive Paid Media ROI Through Social Media

AUSTIN, TX -- (Marketwired) -- 06/17/13 -- VivaKi, a global leader in digital advertising solutions, and Mass Relevance, the technology leader in social curation and integration, today announced a strategic partnership to drive paid media ROI through engaging, interactive social experiences. The partnership will give all Publicis Groupe agencies access to the Mass Relevance platform and product suite to create and integrate social media experiences on client-maintained properties across any digital device and surface. "Mass Relevance captured our attention because they are the only company that can curate all of the social conversations taking place across every major platform, filter these conversations and infuse them into a branded experience in real time," said Rishad Tobaccowala, Chief Strategy and Innovation Officer at VivaKi. "The ability to curate conversat... (more)

Medivo Raises $15 Million to Further Expand Analytics Platform

Medivo Inc., a health monitoring platform that regularly connects doctors, consumers and clinical labs, today announced that it raised a $15 million Series B financing round led by the Merck Global Health Innovation Fund (GHIF), with participation from existing investors Safeguard Scientifics, Inc. (NYSE:SFE) and MentorTech Ventures. To date, Medivo has raised more than $22 million to support its analytics capabilities and innovative health data platform, including a $7 million Series A financing in late 2011. “We are extremely pleased to receive this additional capital to support our rapid growth,” said Sundeep Bhan, Chief Executive Officer and a Co-Founder of Medivo. “For the past three years, Medivo has doubled its growth year-over-year and is well-positioned for continued growth. The new round of funding will be used to continue expanding our clinical data platf... (more)

JSS Medical Research in Montréal, Québec, Canada completes acquisition of LatAm Clinical Trials in South & Central America

MONTREAL, Sept. 26, 2013 /PRNewswire/ - JSS Medical Research, a full-service Contract Research Organization (CRO), announced today that it has acquired LatAm Clinical Trials, a multinational CRO in South and Central America. LatAm Clinical Trials was founded by a group of entrepreneurs in 2005 and has provided clinical research support to the pharmaceutical industry for Phase I - IV and post-marketing studies with offices in the USA, Colombia and Panama. The clinical research staff is located in the Andean Countries of South America and in Central America, giving access to substantial underutilized medical expertise and infrastructure throughout an area that includes Colombia, Panama, Costa Rica, Guatemala, Dominican Republic, Peru, Venezuela and Ecuador. LatAm Clinical Trials' geographic reach is extended to additional countries in Latin America through partnerships... (more)